UBS Group’s Humana HUM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.4M | Sell |
60,100
-79,500
| -57% | -$16.3M | ﹤0.01% | 3289 |
|
|
2025
Q4 | $35.8M | Sell |
139,600
-51,700
| -27% | -$13.6M | 0.01% | 1992 |
|
|
2025
Q3 | $49.8M | Sell |
191,300
-85,300
| -31% | -$22.4M | 0.01% | 1627 |
|
|
2025
Q2 | $67.6M | Sell |
276,600
-150,700
| -35% | -$37.6M | 0.01% | 1254 |
|
|
2025
Q1 | $113M | Sell |
427,300
-250,600
| -37% | -$67.8M | 0.02% | 847 |
|
|
2024
Q4 | $172M | Buy |
677,900
+207,000
| +44% | +$55.5M | 0.03% | 585 |
|
|
2024
Q3 | $149M | Buy |
470,900
+9,300
| +2% | +$3.31M | 0.03% | 534 |
|
|
2024
Q2 | $172M | Sell |
461,600
-18,000
| -4% | -$6.08M | 0.04% | 404 |
|
|
2024
Q1 | $166M | Buy |
479,600
+190,100
| +66% | +$72M | 0.04% | 422 |
|
|
2023
Q4 | $133M | Buy |
289,500
+26,300
| +10% | +$13M | 0.04% | 462 |
|
|
2023
Q3 | $128M | Buy |
263,200
+68,100
| +35% | +$32M | 0.04% | 408 |
|
|
2023
Q2 | $87.2M | Sell |
195,100
-32,700
| -14% | -$16.5M | 0.03% | 548 |
|
|
2023
Q1 | $111M | Sell |
227,800
-16,700
| -7% | -$8.26M | 0.04% | 423 |
|
|
2022
Q4 | $125M | Buy |
244,500
+118,300
| +94% | +$62.2M | 0.05% | 414 |
|
|
2022
Q3 | $61.2M | Buy |
126,200
+7,100
| +6% | +$3.45M | 0.03% | 602 |
|
|
2022
Q2 | $55.7M | Buy |
119,100
+37,700
| +46% | +$16.8M | 0.02% | 677 |
|
|
2022
Q1 | $35.4M | Buy |
81,400
+8,600
| +12% | +$3.6M | 0.01% | 1053 |
|
|
2021
Q4 | $33.8M | Buy |
+72,800
| New | +$32.2M | 0.01% | 1212 |
|
|
2019
Q4 | – | Sell |
-37,600
| Closed | -$9.61M | – | 8242 |
|
|
2019
Q3 | $9.61M | Buy |
37,600
+33,600
| +840% | +$9.42M | ﹤0.01% | 1793 |
|
|
2019
Q2 | $1.06M | Hold |
4,000
| – | – | ﹤0.01% | 3718 |
|
|
2019
Q1 | $1.06M | Buy |
+4,000
| New | +$1.15M | ﹤0.01% | 3535 |
|
|
2018
Q2 | – | Sell |
-111,000
| Closed | -$29.8M | – | 8094 |
|
|
2018
Q1 | $29.8M | Buy |
+111,000
| New | +$30M | 0.01% | 902 |
|
|
2017
Q2 | – | Sell |
-432,800
| Closed | -$89.2M | – | 7796 |
|
|
2017
Q1 | $89.2M | Sell |
432,800
-19,500
| -4% | -$4.03M | 0.05% | 370 |
|
|
2016
Q4 | $92.3M | Sell |
452,300
-28,200
| -6% | -$5.38M | 0.05% | 357 |
|
|
2016
Q3 | $85M | Buy |
480,500
+265,500
| +123% | +$46.1M | 0.05% | 363 |
|
|
2016
Q2 | $38.7M | Buy |
215,000
+200,000
| +1,333% | +$35.5M | 0.02% | 604 |
|
|
2016
Q1 | $2.74M | Sell |
15,000
-15,500
| -51% | -$2.69M | ﹤0.01% | 2392 |
|
|
2015
Q4 | $5.45M | Hold |
30,500
| – | – | ﹤0.01% | 1888 |
|
|
2015
Q3 | $5.46M | Sell |
30,500
-84,700
| -74% | -$15.7M | ﹤0.01% | 1844 |
|
|
2015
Q2 | $22M | Buy |
115,200
+82,700
| +254% | +$15.3M | 0.01% | 921 |
|
|
2015
Q1 | $5.79M | Buy |
32,500
+1,600
| +5% | +$253K | ﹤0.01% | 1944 |
|
|
2014
Q4 | $4.44M | Buy |
+30,900
| New | +$4.22M | ﹤0.01% | 2197 |
|
Other funds holding HUM
VCM
VPM
SC
UBS Group's HUM Position: Q1 2026 in Review
UBS Group reduced its Humana (HUM) stake by 28% in Q1 2026, selling an estimated $33.4M and leaving 415,336 shares worth $72M. The position accounts for 0.01% of the portfolio, ranked #1296.
UBS Group first reported a position in HUM in Q4 2014 and has held it in 46 quarters since. The position peaked at $188M in Q4 2017. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.
- UBS Group held 415,336 shares of Humana worth $72M as of Q1 2026.
- UBS Group sold 163,055 Humana shares in Q1 2026, an estimated $33.4M.
- Humana made up 0.01% of UBS Group's portfolio in Q1 2026, its #1296 holding.
- UBS Group first reported a position in Humana in Q4 2014 and has held it in 46 quarters since.
- UBS Group's Humana position peaked at $188M in Q4 2017.
- 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.